← Back to Clinical Trials
Recruiting NCT07147608

NCT07147608 SAPHIR2 : Simplification of PHysical Activity Assessment by Rapid Interrogation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07147608
Status Recruiting
Phase —
Sponsor University Hospital, Angers
Condition General Population (no Specific Condition or Disease)
Study Type OBSERVATIONAL
Enrollment 118 participants
Start Date 2025-12-19
Primary Completion 2027-06

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
actimeter wearingphysical activities questionnaires

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 118 participants in total. It began in 2025-12-19 with a primary completion date of 2027-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

A multicentric, non-interventional study using a clinical questionnaire (SAPHIR) and activity monitor (Activ-PAL) to estimate the level of physical activity in the general population. This study compares the level of physical activity reported by the SAPHIR questionnaire with the activity recorded by the activity monitor during the same period, in order to determine if the SAPHIR score is able to represent the measured physical activity, in a simple and easily calculable manner. Hypothesis: The aim of this work is to propose a new questionnaire that is simple to complete by the patient,quick to analyse and directly calculable by the doctor and adapted to the general population, whether during the initial evaluation or the follow-up. Indeed, these scores are rarely used outside the context of the prescription of physical activity in specialized centers. Moreover, a tool suited to the constraints of community medicine seems necessary, given the growth of the prescription of physical activity in primary care. The idea behind this new questionnaire is to obtain a score ranging from 0 to 100 that can be calculated through simple mental arithmetic, which is not the case for most existing questionnaires, in particular the IPAQ.

Eligibility Criteria

Inclusion criteria: * Patients referred for a consultation at one of the participating centers * Patients over 18 years old with no upper age limit Non-inclusion criteria: * Patients with a contra-indication to walking * Professional athletes or patients participating in endurance sports competitions * Patients refusing to participate in the study * Patients unable to understand the objectives or instructions of the study Exclusion criteria: -Patients with Activ-PAL recordings of less than 3 days

Contact & Investigator

Central Contact

Simon LECOQ, MD

✉ Simon.Lecoq@chu-angers.fr

📞 02 41 35 36 37

Principal Investigator

Simon LECOQ, MD

PRINCIPAL INVESTIGATOR

University Hospital, Angers

Frequently Asked Questions

Who can join the NCT07147608 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying General Population (no Specific Condition or Disease). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07147608 currently recruiting?

Yes, NCT07147608 is actively recruiting participants. Contact the research team at Simon.Lecoq@chu-angers.fr for enrollment information.

Where is the NCT07147608 trial being conducted?

This trial is being conducted at Angers, France, Cholet, France, Le Mans, France.

Who is sponsoring the NCT07147608 clinical trial?

NCT07147608 is sponsored by University Hospital, Angers. The principal investigator is Simon LECOQ, MD at University Hospital, Angers. The trial plans to enroll 118 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology